en · de · es
sr9009-notes.peptides7501.com › Guide › Background And Receptor Mechanism — Beginner to Advanced

Background And Receptor Mechanism — Beginner to Advanced

By Editorial Desk · published 2025-08-08 · last reviewed 2025-09-08 · Guide

REV-ERB is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2025-09-08. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.

Background and Mechanism of SR9009

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

Background and Pharmacological Mechanism

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

Related pages on this site

Mechanism and Preclinical Findings

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

SR9009 Identity and Mechanism

SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.

REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

Background from the literature

The success of the Half-Life series has spurred the creation of several spin-off games for Half-Life 2. Codename Gordon (sometimes called Codename: Gordon) is a two-dimensional Flash sidescroller shooter developed by NuclearVision, and was released over Valve's Steam online delivery system on May 18, 2004, as a promotional game for the then-upcoming Half-Life 2. Characters from Half-Life have appeared in other games. Peggle Extreme, a special edition of Peggle bundled with the PC version of The Orange Box features levels based on Half-Life 2, Team Fortress 2 and Portal. The headcrab is also an unlockable character in Super Meat Boy when bought on Steam. The Headcrab also appeared in an April Fools event in the MMO Vindictus as an event item along with the Crowbar, possibly due to the game being created on the Source Engine as well. In the game Magicka there is a playable character (after the addition of a DLC), which closely resembles the original zombie from the Half-Life universe, equipped with a crowbar. Gordon also appears in Renegade Ops and the headcrab is available as a pet in Torchlight 2. Half-Life has also inspired a number of fan-made mods, some which have gained recognition on their own. Garry's Mod started as a sandbox mode using Half-Life 2 assets but since has become a commercial product and given users the ability to incorporate other assets. Among notable fan-made campaigns is Minerva, which was designed to extend the story from Half-Life 2.

Support for teens (archive) University of Maryland guide to puberty and adolescence Growing Up Sexually: A World Atlas Pictures and detailed information about breast development during puberty Puberty in females: interactive animation of Tanner stages Puberty in males: interactive animation of Tanner stages

In the second half of the 18th century, Britain, and later continental Europe and the United States, experienced the Industrial Revolution. This was the first time during which lead production rates exceeded those of Rome. Britain was the leading producer, losing this status by the mid-19th century with the depletion of its mines and the development of lead mining in Germany, Spain, and the United States. By 1900, the United States was the leader in global lead production, and other non-European nations—Canada, Mexico, and Australia—had begun significant production; production outside Europe exceeded that within. A great share of the demand for lead came from plumbing and painting—lead paints were in regular use. At this time, more (working class) people were exposed to the metal and lead poisoning cases escalated. This led to research into the effects of lead intake. Lead was proven to be more dangerous in its fume form than as a solid metal. Lead poisoning and gout were linked; British physician Alfred Baring Garrod noted a third of his gout patients were plumbers and painters. The effects of chronic ingestion of lead, including mental disorders, were also studied in the 19th century. The first laws aimed at decreasing lead poisoning in factories were enacted during the 1870s and 1880s in the United Kingdom.

Sources: en.wikipedia.org

Further detail

Siddhartha Gautama was said to have been a "mahapurisa" (great man) who could have chosen to become a wheel turning king, but instead became the spiritual counterpart to such a king, a wheel turning sage, that is, a Buddha. In his explanation of the term "turning the wheel of Dharma", the Theravada exegete Buddhaghosa explains that this "wheel" which the Buddha turned is primarily to be understood as wisdom, knowledge, and insight (ñāṇa). This wisdom has two aspects, paṭivedha-ñāṇa, the wisdom of self-realisation of the Truth and desanā-ñāṇa, the wisdom of proclamation of the Truth. The dharmachakra symbol also points to the central Indian idea of "Dharma", a complex and multivalent term which refers to the eternal cosmic law, universal moral order and in Buddhism, the very teaching and path expounded by the Buddha. In Buddhist art at early sites such as Bharhut and Sanchi, the dharmachakra was often used as a symbol of Gautama Buddha himself. The symbol is often paired with the triratna (triple jewel) or trishula (trident) symbolizing the triple gem, umbrellas (chatra), symbols of sovereignty and royal power, gems and garlands. It is also sometimes depicted alongside animals such as lions, or deer. There are different designs of the Buddhist dharmachakra with 8, 12, 24 or more spokes. In different Buddhist traditions, the different number of spokes may represent different aspects of the Buddha's Dharma (teaching).

Ants attack and defend themselves by biting and, in many species, by stinging often injecting or spraying chemicals. Bullet ants (Paraponera), located in Central and South America, are considered to have the most painful sting of any insect, although it is usually not fatal to humans. This sting is given the highest rating on the Schmidt sting pain index. The sting of jack jumper ants can be lethal for humans, and an antivenom has been developed for it. Fire ants, Solenopsis spp., are unique in having a venom sac containing piperidine alkaloids. Their stings are painful and can be dangerous to hypersensitive people. Formicine ants secrete a poison from their glands, made mainly of formic acid. Pseudoneoponera (formerly Pachycondyla) produce a string of foam with bitter-tasting cyclic dipeptides from their venom glands when disturbed.

The next few years saw the seeming recovery of Austria's position on the international scene following the near disasters of 1848–1849. Under Schwarzenberg's guidance, Austria was able to stymie Prussian scheming to create a new German Federation under Prussian leadership, excluding Austria. After Schwarzenberg's premature death in 1852, he could not be replaced by statesmen of equal stature, and the emperor himself effectively took over as prime minister. He established absolutist rule by issuing the March Constitution (Austria) in 1849. This was in turn revoked by the Silvesterpatent. Seeking to borrow money on foreign markets, he relented and issued the February Patent in 1861 which established the Empire's constitution. He was one of the most prominent Roman Catholic rulers in Europe, and a fierce enemy of Freemasonry.

Sources: en.wikipedia.org

Supporting material

=== Changes that occur during the onset of gingivitis and periodontitis and its role in bleeding on probing === Following the infiltration of bacteria and its products within the sulcular epithelium, the inflammatory response triggers the release of matrix metalloproteinases which cause collagen destruction. Studies suggest that this mechanism is through the activation of Toll-Like Receptors (TLRs, such as TLR-9) which are present on epithelial cells upon binding with bacterial products (such as lipopolysaccharides, unmyelinated CpG motifs). The expression of these collagenolytic matrix metalloproteinases like MMP-13 and activated NF-κB subunit p65 (a type of transcription factor) was more commonly present in periodontitis tissue compared to gingivitis tissue, indicating that the extent of connective tissue destruction accelerates with the progression of the disease. As an effort to curb the incoming bacterial invasion, the basal cells of the sulcular epithelium, being triggered by the ongoing inflammation, proliferate in hopes to maintain an intact barrier against the bacteria and their products. Due to the ongoing inflammation, engorgement of vessels and vasodilation occurs at the underlying connective tissue of the sulcular epithelium. The concurrent destruction of the collagen will then result in the thinning or ulceration of the sulcular epithelium, making the engorged and more abundant blood capillaries more susceptible to rupture upon innocuous mechanical stimuli (such as those during toothbrushing, probing, flossing, eating).

== Metabolism == The two bioactive forms of vitamin B12 are methylcobalamin in cytosol and adenosylcobalamin in mitochondria. The cyanide is converted to thiocyanate and excreted by the kidney. The MMACHC gene product catalyzes the decyanation of cyanocobalamin as well as the dealkylation of alkylcobalamins including methylcobalamin and adenosylcobalamin. The MMACHC gene product is characterised as a cyanocobalamin reductase (cyanide-eliminating) and an alkylcobalamin reductase. It enables the interconversion of cyano- and alkylcobalamins. Endogenous vitamin B12 becomes inactive when exposed to hydrogen cyanide and nitric oxide in cigarette smoke. More specifically, it causes the active forms to convert to cyanocobalamin, causing a functional deficiency. Functional vitamin B12 deficiency can also develop with heavy regular use of nitrous oxide N2O, also known as "laughing gas", by oxidizing the cobalt atom and inactivating the vitamin. Used for anaesthesia in a clinical setting or as a propellant gas, it's commonly abused as a recreational drug. The enzymes that use B12 as a built-in cofactor are methylmalonyl-CoA mutase (PDB 4REQ) and methionine synthase (PDB 1Q8J).

=== Second formation === The division was reconstituted starting in March 1945 and placed under the operational control of the 2nd Army (Army Group Vistula) in West Prussia. On 10 March 1945, the division was reformed near Schwedt with only two regiments. The "Shadow Division Hannover" was utilized for this purpose. Grenadier Regiment 1093 was not re-established, and the artillery regiment consisted of only a single battalion. Subsequently, the division was assigned to the 3rd Panzer Army and deployed on the Oder front against the Red Army. In May 1945, the 547th Volksgrenadier Division surrendered to US forces near Schwerin in Mecklenburg.

=== Chemical properties === Doxycycline, doxycycline monohydrate and doxycycline hyclate are yellow, crystalline powders with a bitter taste. The latter smells faintly of ethanol, a 1% aqueous solution has a pH of 2–3, and the specific rotation is

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

What is SR9009?

SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.

Network